gastric inhibitory peptide definition has been demonstrated to inhibit gastric acid secretion - Gastric inhibitory peptidefunction GIP belongs to the incretin family of hormones Understanding Gastric Inhibitory Peptide: A Key Regulator of Glucose Metabolism

Gastric inhibitory peptidestimulus Gastric inhibitory peptide (GIP), also widely recognized as glucose-dependent insulinotropic polypeptide (GIP), is a crucial gastrointestinal hormone that plays a significant role in the regulation of postprandial glucose metabolism. First isolated in 1973, this peptide hormone has evolved from being known primarily for its inhibitory effects on gastric acid secretion to being understood as a paramount player within the incretin family of hormones.

The Dual Identity: Gastric Inhibitory Peptide and Glucose-Dependent Insulinotropic Polypeptide

The dual nomenclature of GIP reflects its historical discovery and its primary physiological function.Gastric Inhibitory Polypeptide (GIP) is defined asa 42-amino-acid gastrointestinal hormonethat mediates insulin secretion in response to nutrient intake, ... Initially termed gastric inhibitory peptide due to observations that intestinal extracts could inhibit gastric acid secretion, further research revealed its more prominent role in stimulating insulin release in a glucose-dependent manner. This latter function led to its redefinition as glucose-dependent insulinotropic polypeptideGastric Inhibitory Polypeptide - an overview. Despite the name change, both terms are still commonly used, with GIP being a frequent abbreviation for bothGIP. Understanding this dual identity is key to grasping its comprehensive physiological impact.

Molecular Structure and Synthesis

Gastric inhibitory peptide is a 42-amino-acid gastrointestinal hormone that belongs to the secretin family of hormones. It is synthesized and secreted primarily by the K cells, which are neuroendocrine cells found in the proximal small intestine, specifically the duodenum and jejunum. The secretion of GIP is stimulated by the presence of nutrients, particularly carbohydrates and fats, in the lumen of the small intestine following a meal作者：K Gupta·2022·被引用次数：26—The glucose-dependent insulinotropic polypeptide (GIP), formerly termed "gastric inhibitory peptide," was first isolated in 1973 from .... This makes GIP a gastrointestinal hormone stimulated after oral nutrient ingestion, but not after intravenous nutrient administration, highlighting its role in responding to ingested foodGastric Inhibitory Polypeptide - an overview.

Physiological Functions: More Than Just Inhibition

While its name suggests a primary inhibitory role, the functions of GIP are far more nuanced and critically important for metabolic homeostasis.

* Insulinotropic Action: The most significant function of GIP is its potent ability to stimulate insulin secretion from pancreatic beta cells. This effect is glucose-dependent, meaning that GIP significantly enhances insulin release only when blood glucose levels are elevatedThe gastric inhibitory polypeptide receptor (GIP-R), also known as the glucose-dependent insulinotropic polypeptide receptor,is a proteinthat in humans is .... This mechanism is a cornerstone of the "incretin effect," which describes the phenomenon where oral glucose intake results in a greater insulin response compared to an equivalent intravenous glucose load. GIP accounts for a substantial portion of this incretin effect, estimated to be between 60% to 80%The Role of GIP Receptor in the CNS for the Pathogenesis of .... Thus, GIP is a 42-amino-acid hormone that stimulates insulin secretion, contributing significantly to the regulation of blood glucose concentrations.

* Inhibition of Gastric Acid Secretion: True to its original name, GIP does possess the ability to inhibit gastric acid secretion.作者：K Gupta·2022·被引用次数：26—The glucose-dependent insulinotropic polypeptide (GIP), formerly termed "gastric inhibitory peptide," was first isolated in 1973 from ... While this effect is less pronounced than its insulinotropic action, it still contributes to the overall digestive process by modulating gastric emptying and acid production in response to nutrient intake.Cat# GIP75-P Description: Gastric Inhibitory Peptide (GIP), ... Research has demonstrated to inhibit gastric acid secretion in various models, though its precise role in human gastric physiology is still a subject of ongoing study.

* Other Potential Roles: Emerging research suggests GIP may have roles beyond glucose metabolism and gastric function. Studies are exploring its influence on lipid metabolism, bone health, and even its presence and function within the central nervous system (CNS), particularly in relation to appetite and satiety regulationGIP.

The Incretin Connection: GIP and GLP-1

GIP is one of the two major incretin hormones, the other being glucagon-like peptide-1 (GLP-1). Both GIP and GLP-1 are both secreted within minutes of nutrient ingestion and work in concert to regulate postprandial glucose levels and facilitate nutrient disposal. While both are insulinotropic, they have distinct effects on other physiological processes. For instance, GLP-1 also promotes satiety and inhibits gastric emptying, whereas GIP's effects in these areas are less pronouncedBiology of Incretins: GLP-1 and GIP. The interplay between GIP and GLP-1 is a critical area of research, particularly in the context of developing therapeutic strategies for diabetes and obesity.

Clinical Significance and Therapeutic Potential

The discovery and understanding of GIP have opened avenues for therapeutic interventions, particularly in managing type 2 diabetes and obesityGastric Inhibitory Peptide (GIP) - Springer Link. GIP belongs to the incretin family of hormones, and targeting its receptor or enhancing its signaling pathways are active areas of pharmaceutical development. Therapies aimed at modulating GIP activity, such as GIP receptor agonists or dual GIP/GLP-1 receptor agonists, are showing promise in improving glycemic control and promoting weight loss. Understanding the nuances of GIP's role, including its potential limitations in certain disease states, is crucial for optimizing these therapeutic approaches.

In summary, gastric inhibitory peptide, or glucose-dependent insulinotropic polypeptide, is a vital peptide hormone that acts as a key regulator of postprandial glucose metabolism. Its primary function in stimulating insulin secretion, coupled with its modulatory effects on gastric function, underscores its importance in maintaining metabolic health. As research continues, our understanding of this remarkable hormone, and its potential for therapeutic application, will undoubtedly deepenGastric inhibitory polypeptide (GIP) is defined asa key regulator of postprandial glucose metabolism. It is also known as glucose-dependent insulinotropic ....